Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry.
Iwamoto T, Kumamaru H, Niikura N, Sagara Y, Miyashita M, Konishi T, Sanuki N, Tanakura K, Nagahashi M, Hayashi N, Yoshida M, Watanabe C, Kinukawa N, Toi M, Saji S. Iwamoto T, et al. Among authors: miyashita m. Breast Cancer. 2024 Mar;31(2):185-194. doi: 10.1007/s12282-024-01545-x. Epub 2024 Feb 6. Breast Cancer. 2024. PMID: 38319565
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
Nakagawa S, Miki Y, Miyashita M, Hata S, Takahashi Y, Rai Y, Sagara Y, Ohi Y, Hirakawa H, Tamaki K, Ishida T, Watanabe M, Suzuki T, Ohuchi N, Sasano H. Nakagawa S, et al. Among authors: miyashita m. Breast Cancer Res Treat. 2016 Jan;155(1):65-75. doi: 10.1007/s10549-015-3668-9. Epub 2015 Dec 29. Breast Cancer Res Treat. 2016. PMID: 26715212
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K, McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H. Kikuchi K, et al. Among authors: miyashita m. Breast Cancer Res Treat. 2017 Dec;166(3):709-723. doi: 10.1007/s10549-017-4464-5. Epub 2017 Aug 22. Breast Cancer Res Treat. 2017. PMID: 28831645
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Guestini F, Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM. Guestini F, et al. Among authors: miyashita m. Breast Cancer Res Treat. 2019 Jan;173(2):275-288. doi: 10.1007/s10549-018-4985-6. Epub 2018 Oct 10. Breast Cancer Res Treat. 2019. PMID: 30306430
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
Miyashita M, Niikura N, Kumamaru H, Miyata H, Iwamoto T, Kawai M, Anan K, Hayashi N, Aogi K, Ishida T, Masuoka H, Iijima K, Masuda S, Tsugawa K, Kinoshita T, Tsuda H, Nakamura S, Tokuda Y. Miyashita M, et al. Ann Surg Oncol. 2019 Aug;26(8):2475-2485. doi: 10.1245/s10434-019-07453-1. Epub 2019 May 17. Ann Surg Oncol. 2019. PMID: 31102090
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study.
Kubo M, Kawai M, Kumamaru H, Miyata H, Tamura K, Yoshida M, Ogo E, Nagahashi M, Asaga S, Kojima Y, Kadoya T, Aogi K, Niikura N, Miyashita M, Iijima K, Hayashi N, Yamamoto Y, Imoto S, Jinno H. Kubo M, et al. Among authors: miyashita m. Breast Cancer Res Treat. 2019 Dec;178(3):647-656. doi: 10.1007/s10549-019-05413-7. Epub 2019 Aug 26. Breast Cancer Res Treat. 2019. PMID: 31451979 Free PMC article.
1,301 results